Bharat Parenterals balance sheet

As of Mar 2023

Total assets: ₹308cr+41.3% on Mar 2022
Shareholders' equity: ₹191cr+15.0% on Mar 2022
Total debt: ₹6.9cr−29.3% on Mar 2022
Cash and investments: ₹6.4cr−57.1% on Mar 2022

₹ crore except per share

Tap a line for its trend	FY23Mar 2023	FY22Mar 2022

Non-current assets
	35.3	39.8
	0.0	0.6
	1.0	1.1
	38.4	4.8
	57.1	26.1
	1.8	2.2
Current assets
	37.8	20.8
	0.0	11.5
	112	73.4
	6.4	3.3
	1.1	1.3
	0.1	0.1
	3.8	24.3
	13.0	8.7
	308	218
Equity
	5.8	5.8
	185	160
	191	166
Liabilities
	0.4	1.0
	6.9	9.7
	47.9	22.5
	10.0	6.2
	1.3	0.9
	0.5	0.9
	10.0	4.2
	308	218

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

BPLPHARMA₹1,912.90

Bharat Parenterals Limited

· Pharma & Health

₹ CrorePeersJENBURPH KPL MAKERSL NOVARTIND PARNAXLAB SGRL SHUKRAPHAR SUNLOCMcap ₹1,105 Cr

View

In ₹ Crore except Per Share As of	FY22 31/03/2022	FY23 31/03/2023
Non-current Assets
+ Property, Plant & Equipment	39.8	35.3
+ Capital Work-in-Progress	0.6	0.0
+ Investment Property	1.1	1.0
+ Non-current Investments	4.8	38.4
+ Other Non-current Financial Assets	26.1	57.1
+ Other Non-current Assets	2.2	1.8
Current Assets
+ Inventories	20.8	37.8
+ Current Investments	11.5	0.0
+ Trade Receivables	73.4	112.4
+ Cash & Cash Equivalents	3.3	6.4
+ Other Bank Balances	1.3	1.1
+ Short-term Loans	0.1	0.1
+ Other Current Financial Assets	24.3	3.8
+ Other Current Assets	8.7	13.0
Total Assets	218.0	308.0
Equity
+ Equity Share Capital	5.8	5.8
+ Other Equity / Reserves	160.4	185.3
Total Equity	166.2	191.1
Liabilities
+ Deferred Tax Liabilities	1.0	0.4
+ Borrowings — Current	9.7	6.9
+ Trade Payables	22.5	47.9
+ Other Current Financial Liab	6.2	10.0
+ Provisions — Current	0.9	1.3
+ Current Tax Liabilities	0.9	0.5
+ Other Current Liabilities	4.2	10.0
Total Equity & Liabilities	218.0	308.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY23 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.